Skip to main content
. 2017 Jan 18;2(2):156–161. doi: 10.1002/epi4.12038

Table 1.

Expected p values. For each drug strength (in %), the expected p values mean ± standard deviation are shown

Drug A—RR50 A—MPC B—RR50 B—MPC C—RR50 C—MPC
10 0.503 ± 0.322 0.367 ± 0.308 0.507 ± 0.323 0.352 ± 0.303 0.509 ± 0.346 0.231 ± 0.268
20 0.293 ± 0.297 0.133 ± 0.205 0.295 ± 0.298 0.115 ± 0.194 0.189 ± 0.256 0.025 ± 0.082
30 0.088 ± 0.161 0.019 ± 0.061 0.081 ± 0.156 0.014 ± 0.054 0.022 ± 0.079 0.000 ± 0.004
40 0.010 ± 0.035 0.001 ± 0.005 0.008 ± 0.031 0.001 ± 0.002 0.000 ± 0.001 0.000 ± 0.000
50 0.000 ± 0.005 0.000 ± 0.000 0.000 ± 0.001 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000

A, clinically reported seizures with electrographic confirmation; B, all clinically reported events; C, all electrographically confirmed seizures; RR50, 50% responder rate, tested with Fisher's exact test; MPC, median percentage change, tested with the Wilcoxon rank‐sum test.